Pazopanib for the first-line treatment of advanced renal cell carcinoma

Technology appraisal guidance
Reference number: TA215
Published: 23 February 2011
Last updated: 01 August 2013

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive
11 November 2013
(109.64 Kb 31 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 06 November 2013